Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
about
IgY antibodies in human nutrition for disease preventionThe staphylococcal enterotoxin (SE) family: SEB and siblingsAntibodies for biodefenseRhesus macaques (Macaca mulatta) are natural hosts of specific Staphylococcus aureus lineagesThe potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureusIsotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin BToxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples.Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodiesNovel targeted immunotherapy approaches for staphylococcal infection.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B.Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.Neutralization of staphylococcal enterotoxin B by an aptamer antagonistThe evolving field of biodefence: therapeutic developments and diagnostics.Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.Bacterial Toxins-Staphylococcal Enterotoxin B.The cell surface proteome of Staphylococcus aureus.Method for generation of peptide-specific IgY antibodies directed to Staphylococcus aureus extracellular fibrinogen binding protein epitope.Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York.Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay.Facile synthesis and photophysical characterization of luminescent CdTe quantum dots for Forster resonance energy transfer based immunosensing of staphylococcal enterotoxin B.Quantum dot-based lateral-flow immunoassay for rapid detection of rhein using specific egg yolk antibodies.Immunization with a nontoxic mutant of staphylococcal enterotoxin A, SEAD227A, protects against enterotoxin-induced emesis in house musk shrews.
P2860
Q26781140-1A0CFEE8-4B78-45AB-92A0-82598D43E523Q26830220-04E75FE5-C61F-4BF0-8364-7AB5C002CF1EQ28394941-0B992A9A-72E6-4F24-93E7-389C8FAFD60AQ28743667-711824DD-C24B-43FF-A284-7EBEF67A3290Q30415990-1181B81C-4833-4D65-9B17-1992EB13AF29Q33558510-8BB8315B-8216-40C3-8B9B-51C5EBFC3E3DQ33716613-DAAAF69A-9E62-4F69-9953-2711E6983095Q33719201-1351B43D-47DD-4B1C-99B3-77E53F5B6A83Q33723258-463DFEE3-7149-49B4-8DF3-C504B3FF0FFFQ33751822-FEE77E6D-16C9-4A77-879B-FCB94F491ED0Q33769260-3A0B5F5A-D4A1-47D5-89B7-504F49C8F3A5Q33813616-D159F6EF-1E41-408F-9045-D02C43DC1AFDQ33821270-BC9A15BC-A02D-4CE8-9488-39B225F8E523Q33877190-25230B89-5549-417A-869B-949BD21E68D6Q33910565-7F4BFB82-3E0B-4006-9E26-1FE929852D00Q34112608-32507809-2B5F-43BC-91CB-2A87CCD13732Q34498690-10D623EB-FCCC-4136-8116-E252B4C0F1B9Q34685363-596A8E2C-4627-4545-8F7F-C88DD3B96D2EQ34739025-B8DA9FF1-52CC-4DBA-89AA-7199CE857277Q35169108-5CDD24E8-58F7-4FBB-98C6-61A840CF7A52Q36085668-256A3205-9291-4E33-8C8F-CCD244BA7B2BQ36970896-17FC0939-58CE-4667-9ABA-0F8A93B34551Q37332203-71053951-8EA1-442E-B13F-6C56CAE2CDB6Q37378451-BF23B075-E339-4D9B-A99B-C8A13239E319Q37883257-8CB71D09-16EB-4A54-9500-500DD49A7661Q41148315-D7BFF8DD-D8D8-42CB-9016-58920372DA63Q41833050-5CBFC9F7-7D8A-4B74-B12C-B0BDD7A84E16Q42628008-C50D6273-5075-43E9-BAC0-4A52F09CBF7EQ45419465-D4CF92DB-C1E1-4246-974F-69C7D58F99F8Q47783837-36E196DC-3493-4938-A239-EF2DEBE36493Q54411256-A64F80E1-2FDB-4C5F-ACC4-BAA5952E8A11
P2860
Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Protection against bacterial s ...... oxin B by passive vaccination.
@en
Protection against bacterial s ...... oxin B by passive vaccination.
@nl
type
label
Protection against bacterial s ...... oxin B by passive vaccination.
@en
Protection against bacterial s ...... oxin B by passive vaccination.
@nl
prefLabel
Protection against bacterial s ...... oxin B by passive vaccination.
@en
Protection against bacterial s ...... oxin B by passive vaccination.
@nl
P2860
P1476
Protection against bacterial s ...... oxin B by passive vaccination.
@en
P2093
Robert E Hunt
Ross D LeClaire
P2860
P304
P356
10.1128/IAI.70.5.2278-2281.2002
P407
P50
P577
2002-05-01T00:00:00Z